FDA Warning Letter — Cheverly Exxon 25417

Case 735309 — FEI 3046816057

The FDA took a Warning Letter action against Cheverly Exxon 25417 on Jul 28, 2026 (Cheverly, MD). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Cheverly Exxon 25417
Date
Jul 28, 2026
Fiscal Year
2026
Product Type
Tobacco
Center
CTP
Location
Cheverly, MD (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.